Erez Chimovits
CIK 1706399 · last filed 2026-08-11
Erez Chimovits is a corporate insider who has filed 23 SEC Form 4 insider transactions across 7 companies since 2018. The most recent filing, for BRVE, was dated Aug 11, 2026. Across all open-market trades the lifetime net is +$64.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $6.0M across reported positions. 4 SEC filings were submitted jointly with OrbiMed Israel BioFund GP Limited Partnership.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.99M
7
23
$64.90M
Filer Profile
601 LEXINGTON AVENUE, 54TH FLOOR
NEW YORK, NY 10022
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) Delisted | Director | 10,235,159 | — | — | $34.92M | 3 | 2026-08-11 |
| UPB | Director | 973,716 | $5.73 | $5.58M | $14.03M | 4 | 2026-06-11 |
| BiomX Inc. (PHGE.U) Delisted | 10%+ Owner | 13,797,997 | $0.90 | $12.42M | -$37.1K | 2 | 2024-05-20 |
| ACET | Director | 43,128 | $9.52 | $410.6K | $0 | 2 | 2021-02-18 |
| LogicBio Therapeutics, Inc. (LOGC) Delisted | Director | 4,126,972 | $7.06 | $29.14M | $13.79M | 5 | 2020-10-05 |
| BiomX Inc. (PHGE.WS) Delisted | Director | 2,313,489 | $0.01 | $20.4K | $199.2K | 4 | 2020-03-27 |
| Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Director | 176,851 | — | — | $2.00M | 3 | 2020-02-25 |
Recent Filings
23 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-11 | Braveheart Bio, Inc. (BRVE) Delisted | Mixed | +11,072,420 | $34.92M | EDGAR |
| 2026-08-07 | Braveheart Bio, Inc. (BRVE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2026-08-07 | Braveheart Bio, Inc. (BRVE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2026-06-11 | UPB | Grant (A) | — | $0 | EDGAR |
| 2025-06-12 | UPB | Grant (A) | — | $0 | EDGAR |
| 2024-10-17 | UPB | Mixed | +4,434,789 | $14.03M | EDGAR |
| 2024-10-15 | UPB | Grant (A) | — | $0 | EDGAR |
| 2024-05-20 | BiomX Inc. (PHGE.U) Delisted | Mixed | +37,024,256 | $9.02M | EDGAR |
| 2024-03-19 | BiomX Inc. (PHGE.U) Delisted | Buy (P) | — | $0 | EDGAR |
| 2021-02-18 | ACET | Grant (A) | +524,349 | $6.82M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.